Integra LifeSciences Holdings CorporationIARTNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$21.41
Net Income/Share$-6.45
Operating CF/Share$1.16
Free CF/Share$-0.19
Cash/Share$3.49
Book Value/Share$13.52
Tangible Book/Share$-9.61
Equity/Share$13.52
Interest Debt/Share$27.22
CapEx/Share$1.35
Dividend/Share$0.00
Valuation
Market Cap$867.72M
Enterprise Value$2.64B
P/E Ratio-1.73P/S Ratio0.53P/OCF Ratio9.57
P/FCF Ratio-59.98
P/B Ratio0.82P/TB Ratio0.82
EV/Sales1.61EV/EBITDA-8.44
Graham Valuation
Graham Number--
Graham Net-Net$-24.75
Profitability
Earnings Yield-57.93%FCF Yield-1.67%ROE-38.51%ROIC-12.32%Return on Tangible Assets-26.47%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF116.20%
CapEx/Revenue6.32%
CapEx/Depreciation0.69
SBC/Revenue1.21%
SG&A/Revenue0.00%
R&D/Revenue6.41%
Liquidity & Solvency
Debt/Equity1.93Debt/Assets0.55Debt/Market Cap2.31
Net Debt/EBITDA-5.67
Current Ratio3.14Interest Coverage-5.45xIncome Quality-0.18Efficiency
Days Sales Outstanding58 days
Days Payables Outstanding44 days
Days Inventory234 days
Receivables Turnover6.27x
Payables Turnover8.28x
Inventory Turnover1.56x
Capital Structure
Tangible Assets-$737.77M
Working Capital$779.53M
Invested Capital$3.13B
Intangibles/Assets48.69%